News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Liquidia Technologies Inc. Chief Scientific Officer to Present at National Forum Focused on Innovations in Glaucoma Treatment



1/29/2013 6:48:00 AM

Liquidia Technologies today announced the company’s Chief Scientific Officer, Benjamin Yerxa, PhD, will participate in a panel presentation and discussion titled “New Horizons in Glaucoma Drug Delivery” at the Glaucoma 360 New Horizons Forum being held on Friday, February 1, 2013, at the Palace Hotel in San Francisco. The conference, presented by Glaucoma Research Foundation (GRF), brings together key clinical, industry, financial and regulatory leaders in a unique exchange on research innovation and advances in glaucoma treatment. Globally, glaucoma is a leading cause of preventable blindness.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES